
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc is experiencing robust organic growth in the behavioral health sector, aided by an increase in specialty admissions, bed expansions, and new facility developments, positioning the company favorably for future revenue growth. The anticipated rise in net PLGL liability signals positive momentum through enhanced operational efficiencies, while planned reductions in capital expenditures for 2026 are expected to significantly boost cash flow. Furthermore, with strong capitalization and a clearly defined strategy for mergers and acquisitions, Acadia is well-equipped to navigate market challenges and capitalize on growth opportunities within the competitive healthcare landscape.
Bears say
Acadia Healthcare Co. Inc. has faced a series of downward adjustments to its financial guidance, primarily due to underestimated PLGL expenses, which are projected to persist through 2026, impacting the company’s EBITDA significantly. The downward revisions reflect a decline in volume and ongoing rate pressure, leading to a revised adjusted EBITDA estimate of $650-660 million for 2025, which is a reduction of approximately 13.4% from initial guidance. In light of these challenges, analysts anticipate continued softness in volumes and a contraction of the enterprise multiple, ultimately projecting a concerning valuation range for the coming years.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares